Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success

Of the 50 companies founded out of Stanford’s Biodesign center, just two have folded. Six were acquired; the rest are "alive and well." The program director shares the secrets behind…

PALO ALTO, Calif. — A series of glass cabinets lines the back wall of this Stanford building, the shelves crowded with health technologies dreamed up here. There’s a bottle of thick blue gel that helps drugs stick inside the colon, a heartbeat-tracking patch, an under-the-sheets sensor that buzzes to prevent night terrors, and a baby doll with a dozen redesigned versions of an umbilical catheter lying next to its blanket.

“My favorite thing is just looking at some of the technologies that have come out,” said Dr. Paul Yock, pointing to a low-cost substitute for the pricey ventilators found in the intensive care unit.

The shelves are a hall of fame of sorts for Yock, a cardiologist and bioengineer who runs Stanford’s

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT8 min gelesen
After 40 Years, The Alzheimer’s Association Sees Signs Of Progress Against A Devastating Disease. Is It Real?
After 40 years, the Alzheimer’s Association sees signs of progress against a devastating disease. Is it real?
STAT6 min gelesen
Opinion: Should ‘Broken’ Genes Be Fixed? My Daughter Changed The Way I Think About That Question
I'm a doctor. I strive to fix things that are broken. Hearts, mostly. But my daughter Ruthie has forever changed my thinking about what needs to be fixed.
STAT4 min gelesen
The Coronavirus Is Picking Up Steam Outside China, Narrowing Chances Of Eliminating It
There's been a sharp rise in the number of cases of the coronavirus in several countries, including South Korea and Iran.